Talis Biomedical Corporation
TLIS · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,849 | -$13,035 | -$13,460 | -$15,682 |
| Dep. & Amort. | $0 | $262 | $614 | $217 |
| Deferred Tax | $0 | $0 | -$3,651 | $2,766 |
| Stock-Based Comp. | $791 | $601 | $1,020 | $1,072 |
| Change in WC | -$4,638 | $371 | $469 | $42 |
| Other Non-Cash | $1,366 | $5,374 | $3,651 | $441 |
| Operating Cash Flow | -$11,330 | -$6,427 | -$11,357 | -$11,144 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $93 | -$70 |
| Net Acquisitions | $84 | $30 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $84 | $30 | $93 | -$70 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2 | -$33 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $2 | $0 | $0 |
| Forex Effect | $776 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,470 | -$6,395 | -$11,264 | -$11,214 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,337 | $76,732 | $87,996 | $100,752 |
| End Cash | $59,867 | $70,337 | $76,732 | $89,538 |
| Free Cash Flow | -$11,330 | -$6,427 | -$11,264 | -$11,214 |